Ethiopia’s successful integration of oxytocin into the vaccine cold chain system offers three critical lessons for health systems in low- and middle-income countries. First, the baseline data was striking: only half of facilities monitored oxytocin temperature daily before reform, demonstrating the urgent need for systematic improvement. Second, the Ministry of Health employed the GRADE Evidence-to-Decision framework over 24 months, bringing rigorous stakeholder engagement to policy development rather than relying on top-down mandates alone.
Third, the initiative strategically leveraged existing vaccine cold chain infrastructure, avoiding duplicate systems and reducing implementation costs while ensuring sustainability. This pragmatic approach acknowledges that health systems in resource-limited settings must maximize existing assets.
These lessons—baseline assessment, structured decision-making, and infrastructure integration—provide a replicable roadmap for countries seeking to strengthen maternal health programmes.
Was this article helpful?
